SEBASTOPOL, CA --
How are cancer cures developed? A step at a time, as a
of clinical trials incrementally shows which treatment variation
Enrollment in clinical trials is necessary if steady progress is
to be made. In childhood cancers, enrollment in clinical trials
60%. Because of the high percentage of families participating,
the cure rate for childhood cancer has jumped from a meager
10% in 1970 to today's overall survival rate of almost 70%.
By contrast, adult cancers typically have only 3% of patients
enrolled in trials. Trials which take years to fill mean that
treatment advances are slow and expensive.
For high-risk cancers, clinical trials offer possible
access to promising new treatments. Many promising biological
treatments, such as Gleevec and Iressa, are currently being
tested on a range of cancers.
Clinical trials also fine-tune treatments that have been shown
to cure, making incremental improvements in the quality of life
cancer patients, during and after treatment.
Patient-Centered Guides encourages patients to consider clinical
trials as one treatment option. We offer several ways to do this:
Cancer Clinical Trials, our website at
www.patientcenters.com/trials, the clinical trials chapter
in each of our books on individual pediatric and adult cancers,
and now the HopeLink searchable database available from our
Patient-Centered Guides is glad to offer a searchable database of
cancer clinical trials, developed and maintained by HopeLink
Corporation. In this, we join other patient-oriented
organizations, such as the Colon Cancer Alliance, Lance Armstrong
the Leukemia & Lymphoma Foundation, National Breast Cancer
National Brain Tumor Foundation, National Ovarian Cancer
Oncology Nursing Society, and Pancreatic Cancer Action Network.
We decided to offer this service after comparing it to
other available search tools.
The HopeLink Clinical Trial Service, a free, easy-to-use,
comprehensive database of over 1,800 cancer trials, provides
patients and advocates with the latest information on drug
therapies under development, including enrollment information and
preliminary eligibility requirements. There is no fee paid to
HopeLink (or us) for patient enrollment.
By pointing patients to this search interface, we hope that
more patients will be aware of and consider clinical trials,
among their treatment options.
About Patient-Centered Guides
We publish clear, concise, easy to understand information about
the medical, practical and emotional aspects of health issues.
Our authors are patient activists, knowledgeable about specific
conditions and diseases, who have built strong and networked
communities of patients, families, and caregivers.
Patient-Centered Guides is a wholly-owned subsidiary of O'Reilly
& Associates, Inc. O'Reilly is recognized worldwide for its
technical books that provide value to people who are experiencing
information pain. O'Reilly publishes books that make a difference
in people's lives.
More information about Patient-Centered Guides is at
HopeLink is a privately held healthcare information technology
company that provides products and services that build efficiency
into the clinical trial process by enabling information access
between drug developers, patients, and their respective agents.
The company's initial product improves access to trial
information and accelerates patient enrollment into trials.
The HopeLink Clinical Trial Service, a comprehensive hosted
database of cancer trial listings, is widely available at the
websites of HopeLink's Syndicated Network partners. Additional
information on HopeLink is available at www.hopelink.com.